|
|
Volumn 276, Issue 16, 1996, Pages 1342-1343
|
|
The FDA's decisions regarding new indications for approved drugs: Where's the evidence?
a
a
JAMA
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NIFEDIPINE;
BLOOD PRESSURE REGULATION;
DRUG APPROVAL;
DRUG LABELING;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERTENSION;
ORAL DRUG ADMINISTRATION;
PEER REVIEW;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SUBLINGUAL DRUG ADMINISTRATION;
TREATMENT INDICATION;
|
|
EID: 0029909071
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.276.16.1342 Document Type: Editorial |
|
Times cited : (14)
|
|
References (0)
|
